Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Clin Immunol ; 41(7): 1446-1456, 2021 10.
Article in English | MEDLINE | ID: covidwho-1453806

ABSTRACT

STAT2 is distinguished from other STAT family members by its exclusive involvement in type I and III interferon (IFN-I/III) signaling pathways, and its unique behavior as both positive and negative regulator of IFN-I signaling. The clinical relevance of these opposing STAT2 functions is exemplified by monogenic diseases of STAT2. Autosomal recessive STAT2 deficiency results in heightened susceptibility to severe and/or recurrent viral disease, whereas homozygous missense substitution of the STAT2-R148 residue is associated with severe type I interferonopathy due to loss of STAT2 negative regulation. Here we review the clinical presentation, pathogenesis, and management of these disorders of STAT2.


Subject(s)
Genetic Diseases, Inborn/genetics , Immune System Diseases/genetics , Interferon Type I/immunology , STAT2 Transcription Factor/genetics , Virus Diseases/genetics , Animals , Gain of Function Mutation , Genetic Diseases, Inborn/immunology , Genetic Predisposition to Disease , Humans , Immune System Diseases/immunology , Loss of Function Mutation , Phenotype , STAT2 Transcription Factor/chemistry , STAT2 Transcription Factor/immunology , Virus Diseases/immunology
SELECTION OF CITATIONS
SEARCH DETAIL